美国整形与重建外科临床试验中的种族与民族代表性:系统综述与Meta分析
该系统综述与Meta分析纳入2012至2022年美国整形与重建外科临床试验,最终36项符合种族与民族报告标准、共7281名受试者(男性446名占6.1%,女性6835名占93.9%)。汇总患病率显示白人78%、黑人或非裔美国人8%、亚洲人1%,西班牙裔7%,少数族裔代表性存在差异,作者认为需减少入组差距并准确报告种族与民族。
要点
- 36项整形与重建外科临床试验共7281名受试者,男性446名占6.1%,女性6835名占93.9%。
- 汇总患病率白人78%(95%CI 73-82%),黑人或非裔美国人8%(95%CI 5-11%),亚洲人1%(95%CI <1-2%)。
- 西班牙裔汇总患病率7%(95%CI 5-9%),非西班牙裔12%(95%CI <1-38%)。
核心结论
- 整形与重建外科临床试验中少数族裔代表性存在差异,作者认为将试验结果推广至一般人群存在明显局限,需要努力减少少数族裔入组差距并准确报告种族与民族。
研究设计与样本
- 系统综述与随机效应比例Meta分析,检索2012至2022年全部美国整形与重建外科临床试验,初检3609项研究,154项归为临床试验,最终36项符合种族与民族报告标准并纳入分析。
主要发现
- 纳入分析的36项试验共7281名受试者,其中男性446名(6.1%),女性6835名(93.9%)。
- 在正确报告种族的试验中,汇总患病率为白人78%(95%CI 73-82%)、黑人或非裔美国人8%(95%CI 5-11%)、亚洲人1%(95%CI <1-2%)、美洲印第安人<1%(95%CI <1-<1%)、太平洋岛民<1%(95%CI <1-<1%)。
- 在正确报告民族的试验中,西班牙裔汇总患病率为7%(95%CI 5-9%),非西班牙裔为12%(95%CI <1-38%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In 1993, the National Institutes of Health Revitalization Act mandated increasing minority and women enrollment in clinical trials (CTs). This study aimed to investigate trends in race and ethnicity enrollment and reporting in US plastic and reconstructive surgery (PRS) CT. METHODS: A comprehensive systematic review was performed. All CTs in PRS from 2012 to 2022 were included. To assess racial and ethnic representation within CTs, a random-effects meta-analysis of proportion was conducted to pool the prevalence of the binomial data. RESULTS: A total of 3609 studies were initially identified in the search strategy, with 154 later classified as CTs in PRS. Only 36 met the eligibility criteria for reporting race and ethnicity and were included in the analysis. A total of 7281 participants were included: 446 (6.1%) males and 6835 (93.9%) females. From CTs that correctly reported race, the pooled prevalence of races were as follows: Whites 78% (95% confidence interval [CI] 73-82%), Black or African Americans 8% (95% CI 5-11%), Asians 1% (95% CI <1-2%), American Indians <1% (95% CI <1-<1%), and Pacific Islanders <1% (95% CI <1-<1%). From the studies that reported ethnicity correctly, the pooled prevalence of Hispanics was 7% (95% CI 5-9%), and Non-Hispanics was 12% (<1-38%). CONCLUSIONS: Disparities in minority representation were present among PRS CTs. This suggests clear limitations in generalizing PRS CT results to the population. Efforts to decrease the gap in minority enrollment and accurately report race and ethnicity are needed in all fields, including plastic surgery.
引用
- Hernandez Alvarez A, Valentine L, Bustos VP, et al. Racial and ethnic representation in united states plastic surgery clinical trials: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2024. PMID: 38484437. doi:10.1016/j.bjps.2024.02.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。